Stay updated on Pembrolizumab in Recurrent PCNSL Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent PCNSL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent PCNSL Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:52:23.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Added revision note: v3.5.0. Removed revision note: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T05:30:54.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision history updated to include v3.4.3 and remove v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T00:47:08.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed older notices (including the lapse in government funding notice and Revision: v3.4.1), which are cosmetic updates and do not modify the study details or core content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T12:34:30.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page now includes a government funding lapse notice with a status update for the NIH Clinical Center, and the site version was updated to v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T06:38:38.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The page adds a Show glossary option and updates metadata labels (Last Update Submitted that Met QC Criteria; Revision: v3.4.0), replacing the previous labels (Last Update Submitted that met QC Criteria) and the No FEAR Act data note.
    Difference
    0.2%
    Check dated 2026-01-28T06:19:25.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent PCNSL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent PCNSL Clinical Trial page.